Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:20 pm Sale |
2021-12-31 | 13G | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 1,760,870 4.200% |
-1,862,094 (-51.40%) |
Filing |
| 2021-03-01 4:07 pm Sale |
2021-02-25 | 13G | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 3,622,964 9.990% |
-877,036 (-19.49%) |
Filing |
| 2020-06-25 4:06 pm Purchase |
2020-06-15 | 13D | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 4,500,000 20.800% |
1,500,000 (+50.00%) |
Filing |
| 2020-06-01 4:05 pm Purchase |
2020-05-20 | 13G | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 3,000,000 19.300% |
3,000,000 (New Position) |
Filing |